Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
✓

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

· แสดงบันทึก
01:59:30
Podcasts
RSS
Link

เกี่ยวกับตอนนี้

Featuring perspectives from Dr Manali Kamdar, Dr Krish Patel and Dr Gilles Salles, including the following topics:

  • Introduction (0:00)
  • Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles (7:05)
  • Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel (26:21)
  • Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar (43:12)
  • CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles (1:08:33)
  • Other Approved and Emerging Novel Therapies for FL — Dr Patel (1:24:44)
  • Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar (1:41:34)

CME information and select publications

ยารักษาโรค
การศึกษา
สุขภาพและฟิตเนส
ยารักษาโรค
วิทยาศาสตร์
ภาษาอังกฤษ
สหรัฐอเมริกา
ใช้APIเพื่อดึงข้อมูลตอนนี้ในJSON

ในตอนนี้

แก้ไขแท็กเหล่านี้

แสดงหมายเหตุ 🔗

00:00:00Introduction
00:07:05Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles
00:26:21Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel
00:43:12Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar
01:08:33CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles
01:24:44Other Approved and Emerging Novel Therapies for FL — Dr Patel
01:41:34Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar

สำเนาบทสนทนา 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

ค้นหาตอนที่ผ่านมา

ค้นหาตอนที่ผ่านมาของ Oncology Today with Dr Neil Love
ฝังแถบค้นหานี้ในเว็บไซต์ของคุณ

ตอนอื่นๆ ใน PODCAST นี้

Chronic Lymphocytic Leukemia — Microlearning Activity 1

Chronic Lymphocytic Leukemia — Microlearning Activity 1

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00) Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor the…
00:24:32
แชร์
บันทึก
Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics: Case: A woman in her mid 50s with BRCA1-mutated recurrent ovarian cancer receives mirvetuximab soravtansine — Ursula Ma…
00:12:17
แชร์
บันทึก
Chronic Lymphocytic Leukemia — Microlearning Activity 2

Chronic Lymphocytic Leukemia — Microlearning Activity 2

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) (0:00) Role of…
00:27:51
แชร์
บันทึก
Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Featuring a slide presentation from Dr Julia Rotow, including the following topics: Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00) Key findings from the Phase III HA…
00:24:03
แชร์
บันทึก
Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics: Introduction and Overview of Bispecific Antibodies in the Clinic (0:00) Current and …
01:58:22
แชร์
บันทึก
ข้อสงวนสิทธิ์: พอดแคสต์และอาร์ตเวิร์คที่ฝังอยู่ในหน้านี้มาจาก Dr. Neil Love ซึ่งเป็นทรัพย์สินของเจ้าของและไม่มีส่วนเกี่ยวข้องหรือรับรองโดย Listen Notes, Inc.
PROMOTED
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Audio to Text

รายการแนะนำ
ใช้ API เพื่อดึงข้อมูลตอนนี้